Loading…
the sparker alert will let you know when a significant move starts with an audio alert, so You'll never miss an Opportunity.
Insight Molecular Diagnostics Inc Is A Pioneering Diagnostics Technology Company Whose Mission Is To Democratize Access To Novel Molecular Diagnostic Testing To Improve Patient Outcomes. The Company'S Flagship Technology Quantifies A Molecular Biomarker Known As Donor-Derived Cell-Free Dna (Dd-Cfdna). It Is Also In The Process Of Rebranding Its Ruo Test Kit, Graftassure, As Graftassureiq, And Rebranding Its Future In-Vitro Diagnostic (Ivd) Test Kit As Graftassuredx. The Company Geographically Operates In The United States, The United Kingdom, Europe, And The Asia-Pacific Regions, With Maximum Revenue Generated From The Usa.